Document Detail

Coagulation problems in liver disease.
MedLine Citation:
PMID:  10850568     Owner:  NLM     Status:  MEDLINE    
Three topics are addressed in this manuscript: (1) the causes of abnormal hemostasis in cirrhosis; (2) the evaluation of hemostasis in cirrhotic patients before invasive procedures or in the presence of bleeding; and (3) the assessment of the effect of recombinant activated factor VII (rFVIIa; NovoSeven, Novo Nordisk A/S, Bagsvaerd, Denmark) on hemostatic function in cirrhotic patients. Laboratory experiments are described that could enhance the understanding of the effect of rFVIIa on blood coagulation during hemostasis in cirrhotic patients.
S I Rapaport
Related Documents :
1318978 - Clinical utility of pulsed doppler in the detection of arterioportal shunting in patien...
25216288 - Prognostic value of newborn hearing screening in patients with myelomeningocele.
18242498 - Role of methotrexate in the treatment of chronic cholestatic disorders.
19453948 - What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic live...
6429988 - Somatomedin a increments are diminished in acromegaly with concomitant hyperprolactinae...
19879968 - Long-term outcome of patients with obscure gastrointestinal bleeding investigated by do...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  11 Suppl 1     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-10-03     Completed Date:  2000-10-03     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  S69-74     Citation Subset:  IM    
University of California, San Diego, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Coagulation*
Blood Coagulation Disorders / blood,  drug therapy,  etiology*
Factor VIIa / therapeutic use
Liver Diseases / blood*,  complications*
Recombinant Proteins / therapeutic use
Reg. No./Substance:
0/Recombinant Proteins; EC VIIa; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. Inter...
Next Document:  Clinical aspects of bleeding complications in cirrhotic patients.